← Back

Sofosbuvir

Hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor
Tablet400 mg17 brands · 16 makers
Sofosbuvir is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor. SOVALDI is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of: Adult patients with genotype 1, 2, 3 or 4 chronic HCV infection without cirrhosis or with compensated cirrhosis as a component of a combination antiviral treatment regimen. Sofosbuvir is listed in Nepal's National List of Essential Medicines (NLEM, Sixth Revision 2021) under Anti-Infective Medicines.
Generic namesofosbuvir
Therapeutic classAnti-Infective Medicines > 6.4.4.2.2 Non-pangenotypic direct-acting antiviral combinations
Form & strength (NLEM)Tablet: 400 mg
Source / स्रोतNational List of Essential Medicines Nepal (2021); NepalDoc medicine catalog

What it's for

SOVALDI is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of: Adult patients with genotype 1, 2, 3 or 4 chronic HCV infection without cirrhosis or with compensated cirrhosis as a component of a combination antiviral treatment regimen. Pediatric patients 3 years of age and older with genotype 2 or 3 chronic HCV infection without cirrhosis or with compensated cirrhosis in combination with ribavirin.

From the U.S. FDA-approved label for Sofosbuvir. Full label: DailyMed.

SOVALDI is a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor indicated for the treatment of: Adult patients with genotype 1, 2, 3 or 4 chronic HCV infection without cirrhosis or with compensated cirrhosis as a component of a combination antiviral treatment regimen. Pediatric patients 3 years of age and older with genotype 2 or 3 chronic HCV infection without cirrhosis or with compensated cirrhosis in combination with ribavirin.

From the U.S. FDA-approved label for Sofosbuvir. Full label: DailyMed.

Testing Prior to the Initiation of Therapy: Test all patients for HBV infection by measuring HBsAg and anti-HBc. Recommended dosage in adults: One 400 mg tablet taken once daily with or without food. Recommended dosage in pediatric patients 3 years of age and older: Recommended dosage of SOVALDI in pediatric patients 3 years of age and older with genotype 2 or 3 HCV using SOVALDI tablets or oral pellets is based on weight.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

When SOVALDI is used in combination with ribavirin or peginterferon alfa/ribavirin, the contraindications applicable to those agents are applicable to combination therapies. Refer to the prescribing information of peginterferon alfa and ribavirin for a list of their contraindications. When used in combination with peginterferon alfa/ribavirin or ribavirin alone, all contraindications to peginterferon alfa and/or ribavirin also apply to SOVALDI combination therapy.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Risk of Hepatitis B Virus Reactivation: Test all patients for evidence of current or prior HBV infection before initiation of HCV treatment. Monitor HCV/HBV coinfected patients for HBV reactivation and hepatitis flare during HCV treatment and post-treatment follow-up. Initiate appropriate patient management for HBV infection as clinically indicated.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following serious adverse reactions are described below and elsewhere in the labeling: Serious Symptomatic Bradycardia When Coadministered with Amiodarone. The most common adverse events (incidence greater than or equal to 20%, all grades) observed with SOVALDI in combination with ribavirin were fatigue and headache.

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

17 products from 16 makers in the NepalDoc medicine catalog use this generic:

BrandCompositionMakerPack
Hepcivir 400mg TabletSofosbuvir (400mg)Asian Pharmaceuticals Pvt. Ltd.
Sofovir 400mg TabletSofosbuvir (400mg)Hetero Drugs Ltd.
Sofuvir 400mg TabletSofosbuvir (400mg)Magnus Pharma Pvt. Ltd.
Cimivir 400mg TabletSofosbuvir (400mg)Bioconstrip of 28 tablets
Hepcinat TabletSofosbuvir (400mg)Natco Pharma Ltdstrip of 28 tablets
Hepcvir 400mg TabletSofosbuvir (400mg)Cipla Ltdstrip of 28 tablets
MY Hep 400mg TabletSofosbuvir (400mg)Mylan Pharmaceuticals Pvt Ltdstrip of 28 tablets
Novisof 400mg TabletSofosbuvir (400mg)Wockhardt Ltdstrip of 28 tablets
Resof 400mg TabletSofosbuvir (400mg)Dr Reddy's Laboratories Ltdstrip of 28 tablets
Sofab 400mg TabletSofosbuvir (400mg)Sun Pharmaceutical Industries Ltdstrip of 28 tablets
Sofcivir TabletSofosbuvir (400mg)Chemo Healthcare Pvt Ltdbottle of 28 tablets
Sofocruz 400mg TabletSofosbuvir (400mg)Torrent Pharmaceuticals Ltdstrip of 28 tablets
Sofocure TabletSofosbuvir (400mg)Emcure Pharmaceuticals Ltdstrip of 10 tablets
Sofokem 400mg TabletSofosbuvir (400mg)Alkem Laboratories Ltdstrip of 28 tablets
Sovaldi 400mg TabletSofosbuvir (400mg)Mylan Pharmaceuticals Pvt Ltdbottle of 28 tablets
Sovihep 400mg TabletSofosbuvir (400mg)Zydus Cadilastrip of 28 tablets
Virso TabletSofosbuvir (400mg)Strides shasun Ltdbottle of 28 tablets

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Store below 30 °C (86 °F). Dispense only in original container Do not use if seal over bottle opening is broken or missing

Storage information from the U.S. FDA-approved label.

Search medicines in the app / एपमा औषधि खोज्नुहोस् Find a pharmacy / फार्मेसी खोज्नुहोस्
+ Safety information

This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.

NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.